LCD glass substrate maker Corning Inc has filed a patent infringement lawsuit with the Intellectual Property Court against AvanStrate Taiwan Inc (安瀚視特台灣), the US company said yesterday.
Corning said in a statement that AvanStrate Taiwan had produced glass substrates using the manufacturing process in its Taiwan Patent No. 570901.
Tainan-based AvantStrate Taiwan is a local unit of Tokyo-based AvanStrate Inc. Its LCD glass substrates are used in flat panels for TVs, notebook computers, mobile phones and other electronic devices. The unit has about 700 employees.
Corning also filed a patent infringement lawsuit against AvanStrate’s South Korean unit, AvanStrate Korea Inc, in the Seoul Central District Court for infringing Korean Patent Nos. 1230754, 1296484, and 0762054, the statement said.
The Japanese glass substrate maker was established as a 50-50 joint venture between Hoya Corp and Nippon Sheet Glass Co in 1991 and was named NH Techno Glass Corp at the time.
The company was renamed AvanStrate in 2008 following a capital injection from Carlyle Group. It began operating in Taiwan in 2000 and South Korea in 2002.
As Taiwan is among the world’s top three LCD panel manufacturing sites, Corning has built two fabs, a research and development center, and its Asia glass technology center in the nation, the company said.
JPMorgan Chase & Co chief executive officer Jamie Dimon on Tuesday quipped that his company is likely to outlast the Chinese Communist Party (CCP), while reiterating the bank’s commitment to the country in wide-ranging comments that also touched on Taiwan, free speech and former US president Donald Trump. “We hope to be there [in China] for a long time,” Dimon told a panel discussion at the Boston College Chief Executives Club. Relaying a “joke” he made during a recent visit to Hong Kong, he said “The communist party is celebrating its 100th year. So is JPMorgan. And I’ll make you a
The Kaohsiung City Government yesterday said it would impose a property hoarding tax as it is seeking to contain speculation in the real-estate market, calling recent price increases “abnormal.” The announcement came in support of the Ministry of Finance’s call for local governments to levy a high tax rate on people with more than one property. Ministry officials on Tuesday discussed strategies to rein in speculation with the nation’s six special municipalities, as well as the Hsinchu city and county governments. About 84,000 out of 1.06 million housing units in Kaohsiung are not residential property, the city government said in a
PharmaEssentia Corp (藥華醫藥) shares have jumped 80.56 percent since the company obtained a US polycythemia vera (PV) drug license for its new interferon drug Besremi (ropeginterferon alfa-2b-njft) on Nov. 12. Shares on Friday closed at NT$195 in Taipei trading, up from the stock’s closing price of NT$108 on Nov. 12. PV is a rare, chronic and life-threatening blood cancer linked to a stem cell mutation in the bone marrow that results in an overproduction of blood cells and places sufferers at risk of having a blood clot, stroke or heart attack. PharmaEssentia is preparing to make Besremi available in the US in the
BOOST EXPECTED: Higher market prices would offset effects of the industry’s transition to more climate-friendly production methods, a company official said China Steel Corp (CSC, 中鋼) expects steel demand to increase on the back of governments around the world subsidizing infrastructure construction amid a stabilizing COVID-19 pandemic, CSC chairman Wong Chao-tung (翁朝棟) told an investors’ meeting yesterday. “After getting through the hard times, I foresee at least one year, very possibly two years, of strong steel market,” Wong said. Calling a dip in steel prices a “short respite for the market,” Wong said that it would likely bounce back early next year on the back of mild winter temperatures around the world allowing construction activity. Despite COVID-19 spikes in some regions and increased